Healthcare-associated Pneumonia (HCAP) Completed Phase 3 Trials for Meropenem (DB00760)

Back to Healthcare-associated Pneumonia (HCAP)

Also known as: Healthcare Associated Pneumonia / Healthcare-Associated Pneumonia / Health Care Associated Pneumonia / Health-Care-Associated Pneumonia / Healthcare associated pneumonia (disorder) / Lung inflammation / Pneumonia, unspecified organism / Pneumonia and influenza &/or pneumonia / Pneumonia / Pneumonia (disorder) / Pneumonia (disorder) [Ambiguous] / Pneumonia NOS / Pneumonia NOS (disorder) / Pulmonitis

Indication	Status	Phase
DBCOND0079191 (Healthcare-associated Pneumonia (HCAP))	Completed	3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03032380	Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens	Treatment	Cefiderocol (DB14879) Linezolid (DB00601) Meropenem (DB00760)
NCT02070757	Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008)	Treatment	Ceftolozane (DB09050) Meropenem (DB00760) Tazobactam (DB01606)